Crossject Société Anonyme Past Earnings Performance
Past criteria checks 0/6
Crossject Société Anonyme's earnings have been declining at an average annual rate of -2.1%, while the Medical Equipment industry saw earnings declining at 1.1% annually. Revenues have been growing at an average rate of 2.9% per year.
Key information
-2.1%
Earnings growth rate
15.2%
EPS growth rate
Medical Equipment Industry Growth | 4.3% |
Revenue growth rate | 2.9% |
Return on equity | n/a |
Net Margin | -444.7% |
Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Crossject Société Anonyme makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 2 | -10 | 8 | 0 |
31 Mar 24 | 3 | -10 | 8 | 0 |
31 Dec 23 | 4 | -9 | 8 | 0 |
30 Sep 23 | 6 | -9 | 8 | 0 |
30 Jun 23 | 7 | -10 | 8 | 0 |
31 Mar 23 | 7 | -11 | 8 | 0 |
31 Dec 22 | 7 | -11 | 7 | 0 |
30 Sep 22 | 7 | -11 | 7 | 0 |
30 Jun 22 | 6 | -11 | 7 | 0 |
31 Mar 22 | 6 | -11 | 6 | 0 |
31 Dec 21 | 6 | -11 | 6 | 0 |
30 Sep 21 | 6 | -10 | 6 | 0 |
30 Jun 21 | 6 | -10 | 6 | 0 |
31 Mar 21 | 5 | -10 | 5 | 0 |
31 Dec 20 | 5 | -10 | 5 | 0 |
30 Sep 20 | 5 | -9 | 5 | 0 |
30 Jun 20 | 5 | -7 | 5 | 0 |
31 Mar 20 | 5 | -7 | 5 | 0 |
31 Dec 19 | 5 | -7 | 4 | 0 |
30 Sep 19 | 4 | -10 | 4 | 0 |
30 Jun 19 | 3 | -12 | 4 | 0 |
31 Mar 19 | 3 | -12 | 4 | 0 |
31 Dec 18 | 2 | -11 | 4 | 0 |
30 Sep 18 | 3 | -9 | 4 | 0 |
30 Jun 18 | 4 | -8 | 4 | 0 |
31 Mar 18 | 4 | -8 | 3 | 0 |
31 Dec 17 | 3 | -8 | 3 | 0 |
30 Sep 17 | 2 | -7 | 3 | 0 |
30 Jun 17 | 2 | -7 | 3 | 0 |
31 Mar 17 | 2 | -7 | 3 | 0 |
31 Dec 16 | 1 | -6 | 2 | 0 |
30 Sep 16 | 1 | -6 | 2 | 0 |
30 Jun 16 | 1 | -5 | 2 | 0 |
31 Mar 16 | 1 | -5 | 2 | 0 |
31 Dec 15 | 2 | -6 | 2 | 0 |
30 Sep 15 | 2 | -6 | 2 | 0 |
30 Jun 15 | 2 | -6 | 2 | 0 |
31 Mar 15 | 2 | -5 | 2 | 0 |
31 Dec 14 | 1 | -4 | 2 | 0 |
30 Sep 14 | 1 | -4 | 2 | 0 |
30 Jun 14 | 1 | -3 | 2 | 0 |
31 Mar 14 | 1 | -3 | 1 | 0 |
31 Dec 13 | 1 | -2 | 1 | 0 |
Quality Earnings: 74C is currently unprofitable.
Growing Profit Margin: 74C is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 74C is unprofitable, and losses have increased over the past 5 years at a rate of 2.1% per year.
Accelerating Growth: Unable to compare 74C's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 74C is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.1%).
Return on Equity
High ROE: 74C's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.